🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles privately for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers market the substance there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users injecting products of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Platform Response and Material Removal

According to the social media company, the platform has taken down violative content and banned related keywords and query recommendations. The company stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Online Trading Operations

Investigations also discovered groups with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, populated with images of slimming results, positive testimonials and step-by-step instructions for mixing or administering at home.

Within moments of joining one group, a vendor posted contact information, where most transactions occur. The seller provided an guidebook and promised shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about weight, health issues or past usage.

Product Details and Costs

Inside these groups, messages display dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it regularly monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they can’t verify. Although the science behind retatrutide is valid, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject patients to possibly serious health risks”.